PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97503720 |
Filing Date: 07/14/2022 |
Input Field |
Entered |
SERIAL NUMBER | 97503720 |
---|---|
MARK INFORMATION | |
*MARK | GENERATIVE BIOLOGY |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | GENERATIVE BIOLOGY |
MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Generate Biomedicines, Inc. |
*MAILING ADDRESS | 55 Cambridge Parkway, Suite 800E |
*CITY | Cambridge |
*STATE (Required for U.S. applicants) |
Massachusetts |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
02142 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 001 |
*IDENTIFICATION | Biological and chemical agents for scientific and research use |
FILING BASIS | SECTION 1(b) |
INTERNATIONAL CLASS | 005 |
*IDENTIFICATION | Pharmaceutical preparations for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders, but excluding DNA-based gene therapy; therapeutic agents for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders but excluding DNA-based gene therapy; therapeutic products for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders, but excluding DNA-based gene therapy |
FILING BASIS | SECTION 1(b) |
ATTORNEY INFORMATION | |
NAME | Christina M. Licursi |
ATTORNEY DOCKET NUMBER | F08292000501 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Wolf, Greenfield & Sacks, P.C. |
STREET | 600 Atlantic Avenue |
CITY | Boston |
STATE | Massachusetts |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 02210 |
PHONE | 617-646-8000 |
FAX | 617-646-8646 |
EMAIL ADDRESS | cxltrademarks@wolfgreenfield.com |
OTHER APPOINTED ATTORNEY | Michael A. Albert, Nicole Davis Amar, Michael J. Attisha, C. Hunter Baker, Jason W. Balich, Melissa Beede, Brandon S. Blackwell, Joseph M. Bowler, Kady S. Bruce, David F. Cauble, Tani Chen, Gitanjali Chimalakonda, Thomas S. Chlebeck, Aya Cieslak-Tochigi, Bryan S. Conley, Gregory F. Corbett, William L. Czaplyski, Cara B. Dawson, Elizabeth A. DiMarco, Heather J. DiPietrantonio, Matthew O. Duffey, Stuart V. Duncan Smith, Roque El-Hayek, Neil P. Ferraro, Emma L. Frank, Thomas A. Franklin, Susmita A. Gadre, Edward R. Gates, Jean Ge, David S. Gesner, Richard F. Giunta, Matthew H. Grady, Patricia L. Granahan, Eric P. Greenwald, Blaine M. Hackman, Philip J. Hamzik, James M. Hanifin, Jr., John S. Harmon, Jason M. Honeyman, Gerald B. Hrycyszyn, Jeffrey D. Hsi, Elisabeth H. Hunt, Robert E. Hunt, Daniel M. Huttle, Robert A. Jensen, Marc S. Johannes, Oona M. Johnstone, Quincy L. Kayton, Hunter D. Keeton, Alexandra K. Kim, Jessamine M. Lee, Kevin Y. Li, Christina M. Licursi, Helen C. Lockhart, Chelsea Loughran, Yue Matthew Ma, Kevin MacDonald, Robert T. Maldonado, John L. Marquardt, Kira-Khanh McCarthy, William R. McClellan, Gabriel J. McCool, Marie A. McKiernan, Michele Moresco, James H. Morris, Elizabeth S. Mulski, Gregory S. Nieberg, Michelle K. Nyein, Timothy J. Oyer, Zachary P. Piccolomini, Michael J. Pomianek, Curtis R. Powell, Randy J. Pritzker, Stephen S. Rabinowitz, Michael N. Rader, Suresh Rav, Laura B. Rogers, Jonathan B. Roses, Daniel G. Rudoy, Edward J. Russavage, Eric J. Rutt, Robert N. Sahr, Anant K. Saraswat, Turhan F. Sarwar, Tonia A. Sayour, Claire E. Schuster, Amanda Slade, Nathan R. Speed, Charles T. Steenburg, Charlotte R. Stewart-Sloan, John L. Strand, Shirley Tan, Andrew J. Tibbetts, Maria A. Trevisan, Michael J. Twomey, John R. Van Amsterdam, Ryan M. Van Olst, Amanda L. Varrichione, Janice A. Vatland, Jessica A. vonReyn, Robert H. Walat, Patrick R.H. Waller, Edmund J. Walsh, Jennifer J. Wang, Daniel T. Wehner, John L. Welch, Adam R. Wichman, Andrew W. Williams, Chelsea E. Witte-Garcia, Douglas R. Wolf, Jie Ziang, Daniel W. Young, Lock See Yu-Jahnes, Adam Z. Zeiger, William Wei Zhang, Norman H. Zivin |
CORRESPONDENCE INFORMATION | |
NAME | Christina M. Licursi |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | cxltrademarks@wolfgreenfield.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | NOT PROVIDED |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 2 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 700 |
*TOTAL FEES PAID | 700 |
SIGNATURE INFORMATION | |
ORIGINAL PDF FILE | hw_10829173108-162036353_ ._F0829.20005US01_GENERAT IVE_BIOLOGY_-_exec_app.pdf |
CONVERTED PDF FILE(S) (4 pages) |
\\TICRS\EXPORT18\IMAGEOUT 18\975\037\97503720\xml1\ APP0003.JPG |
\\TICRS\EXPORT18\IMAGEOUT 18\975\037\97503720\xml1\ APP0004.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\975\037\97503720\xml1\ APP0005.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\975\037\97503720\xml1\ APP0006.JPG | |
SIGNATORY'S NAME | Sean Martin |
SIGNATORY'S POSITION | Chief Legal Officer, General Counsel |
SIGNATURE METHOD | Handwritten |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97503720 |
Filing Date: 07/14/2022 |
The applicant's current Correspondence Information: |
Christina M. Licursi |
PRIMARY EMAIL FOR CORRESPONDENCE: cxltrademarks@wolfgreenfield.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT
PROVIDED Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |